Cargando…
Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose‐6‐phosphate isomerase peptide‐induced arthritis
INTRODUCTION: Combination treatment with fingolimod (FTY720) plus pathogenic antigen is thought to prevent glucose‐6‐phosphate isomerase (GPI)(325‐339)‐induced arthritis progression by effective induction of immune tolerance. Here, we examined the efficacy of this combination treatment on remission...
Autores principales: | Yoshida, Yuya, Mikami, Norihisa, Matsushima, Yuki, Miyawaki, Mai, Endo, Hiroki, Banno, Rie, Tsuji, Takumi, Fujita, Tetsuro, Kohno, Takeyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004282/ https://www.ncbi.nlm.nih.gov/pubmed/27621810 http://dx.doi.org/10.1002/iid3.111 |
Ejemplares similares
-
Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, examined in non‐obese diabetic mice
por: Tsuji, Takumi, et al.
Publicado: (2012) -
Therapeutic approach for type 1 diabetes mellitus using the novel immunomodulator FTY720 (fingolimod) in combination with once‐daily injection of insulin glargine in non‐obese diabetic mice
por: Tsuji, Takumi, et al.
Publicado: (2011) -
Intravenous lipid emulsion therapy for acute clomipramine intoxication in rats
por: Tsuji, Takumi, et al.
Publicado: (2018) -
Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice
por: Tsuji, Takumi, et al.
Publicado: (2022) -
Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)